These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Successful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review. Shirai T; Onishi A; Waki D; Saegusa J; Morinobu A Medicine (Baltimore); 2018 Jun; 97(23):e11045. PubMed ID: 29879072 [TBL] [Abstract][Full Text] [Related]
3. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease. Nishimura Y; Fajgenbaum DC; Pierson SK; Iwaki N; Nishikori A; Kawano M; Nakamura N; Izutsu K; Takeuchi K; Nishimura MF; Maeda Y; Otsuka F; Yoshizaki K; Oksenhendler E; van Rhee F; Sato Y Am J Hematol; 2021 Oct; 96(10):1241-1252. PubMed ID: 34265103 [TBL] [Abstract][Full Text] [Related]
5. TAFRO Syndrome: A Syndrome or a Subtype of Multicentric Castleman Disease? Takai K Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540266 [TBL] [Abstract][Full Text] [Related]
6. TAFRO Syndrome and Elusive Diagnosis of Idiopathic Multicentric Castleman Disease Treated with Empiric Anti-Interleukin-6 Therapy. Williams C; Phillips A; Aggarwal V; Slonim LB; Fajgenbaum DC; Karmali R Case Rep Oncol; 2021; 14(3):1359-1365. PubMed ID: 34720942 [TBL] [Abstract][Full Text] [Related]
7. An extranodal histopathological analysis of idiopathic multicentric Castleman disease with and without TAFRO syndrome. Kurose N; Mizutani KI; Kumagai M; Shioya A; Guo X; Nakada S; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Kojima M; Nakamura S; Kida M; Yamada S Pathol Res Pract; 2019 Mar; 215(3):410-413. PubMed ID: 30642741 [TBL] [Abstract][Full Text] [Related]
8. TAFRO Syndrome. Igawa T; Sato Y Hematol Oncol Clin North Am; 2018 Feb; 32(1):107-118. PubMed ID: 29157612 [TBL] [Abstract][Full Text] [Related]
9. International definition of iMCD-TAFRO: future perspectives. Nishimura Y; Nishimura MF; Sato Y J Clin Exp Hematop; 2022 Jun; 62(2):73-78. PubMed ID: 35474036 [TBL] [Abstract][Full Text] [Related]
10. Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease? Fujimoto S; Sakai T; Kawabata H; Kurose N; Yamada S; Takai K; Aoki S; Kuroda J; Ide M; Setoguchi K; Tsukamoto N; Iwao-Kawanami H; Kawanami T; Mizuta S; Fukushima T; Masaki Y Am J Hematol; 2019 Sep; 94(9):975-983. PubMed ID: 31222819 [TBL] [Abstract][Full Text] [Related]
11. The first case of thrombocytopenia, anasarca, fever, renal impairment or reticulin fibrosis, and organomegaly (TAFRO) syndrome with unilateral adrenal necrosis: a case report. Fujiwara Y; Ito K; Takamura A; Nagata K J Med Case Rep; 2018 Oct; 12(1):295. PubMed ID: 30293532 [TBL] [Abstract][Full Text] [Related]
12. Characteristics of thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly syndrome: a retrospective study from a large Western cohort. Maisonobe L; Bertinchamp R; Damian L; Gérard L; Berisha M; Guillet S; Fieschi C; Malphettes M; Fadlallah J; Hié M; Dunogué B; De Wilde V; Vandergheynst F; Zafrani L; Grall M; Saada N; Garzaro M; Oksenhendler E; Galicier L; Boutboul D Br J Haematol; 2022 Feb; 196(3):599-605. PubMed ID: 34585382 [TBL] [Abstract][Full Text] [Related]
13. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature. Zhou Q; Zhang Y; Zhou G; Zhu J BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930 [TBL] [Abstract][Full Text] [Related]